Healthy Volunteers - Male and Female
1
Pipeline Programs
5
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Orna TherapeuticsORN252
Qilu PharmaceuticalQLS7305 Injection
ParexelKP-001
CleneCNM-Au8
Clinical Trials (4)
Total enrollment: 206 patients across 4 trials
A Study of ORN252 in Healthy Participants
Start: Mar 2026Est. completion: Mar 202720 patients
Phase 1Recruiting
A Phase I Trial of Subcutaneous QLS7305 in Healthy Adults
Start: Jan 2026Est. completion: Dec 202760 patients
Phase 1Not Yet Recruiting
A Study to Evaluate the Effects of KP-001 on the QT/QTc Intervals in Healthy Adults
Start: Oct 2024Est. completion: Mar 202540 patients
Phase 1Completed
A Phase I SAD and MAD Clinical Trial of CNM-Au8 in Healthy Male and Female Volunteers
Start: Apr 2015Est. completion: Oct 201686 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 206 patients
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.